PIETRANGELO, Antonello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.891
EU - Europa 14.232
AS - Asia 13.208
SA - Sud America 2.037
AF - Africa 196
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 20
AN - Antartide 1
Totale 60.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.521
GB - Regno Unito 4.655
CN - Cina 4.571
SG - Singapore 4.062
IT - Italia 3.262
BR - Brasile 1.702
HK - Hong Kong 1.679
SE - Svezia 1.620
DE - Germania 1.136
FI - Finlandia 780
VN - Vietnam 723
UA - Ucraina 709
KR - Corea 679
RU - Federazione Russa 598
TR - Turchia 483
FR - Francia 387
BG - Bulgaria 293
CA - Canada 217
IN - India 208
NL - Olanda 198
ID - Indonesia 188
AR - Argentina 142
BD - Bangladesh 108
JP - Giappone 102
MX - Messico 94
PL - Polonia 80
BE - Belgio 74
IE - Irlanda 74
ZA - Sudafrica 69
IQ - Iraq 64
AT - Austria 61
LT - Lituania 57
MY - Malesia 56
ES - Italia 55
AU - Australia 50
EC - Ecuador 46
PK - Pakistan 41
RO - Romania 40
CO - Colombia 39
IR - Iran 37
CH - Svizzera 30
EG - Egitto 30
CL - Cile 25
VE - Venezuela 25
AE - Emirati Arabi Uniti 24
MA - Marocco 23
CZ - Repubblica Ceca 21
PE - Perù 20
GR - Grecia 18
IL - Israele 17
PY - Paraguay 17
SA - Arabia Saudita 17
UZ - Uzbekistan 17
KE - Kenya 15
PH - Filippine 13
BO - Bolivia 12
DZ - Algeria 12
OM - Oman 12
PT - Portogallo 12
TW - Taiwan 12
AZ - Azerbaigian 11
HU - Ungheria 11
JM - Giamaica 11
TN - Tunisia 11
EU - Europa 10
KZ - Kazakistan 10
NP - Nepal 9
PS - Palestinian Territory 9
TH - Thailandia 9
AL - Albania 8
HN - Honduras 8
JO - Giordania 8
RS - Serbia 8
CR - Costa Rica 7
ET - Etiopia 7
LB - Libano 7
SI - Slovenia 7
BY - Bielorussia 6
GE - Georgia 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
XK - ???statistics.table.value.countryCode.XK??? 6
DO - Repubblica Dominicana 5
NO - Norvegia 5
PA - Panama 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
GT - Guatemala 4
LK - Sri Lanka 4
LV - Lettonia 4
NG - Nigeria 4
AM - Armenia 3
BZ - Belize 3
EE - Estonia 3
GA - Gabon 3
HR - Croazia 3
KW - Kuwait 3
NI - Nicaragua 3
Totale 60.582
Salva come PNG Salva come JPEG
Città #
Fairfield 3.380
Southend 3.205
Santa Clara 2.757
Ashburn 2.633
Singapore 2.469
Woodbridge 2.261
Hefei 1.857
Chandler 1.794
Houston 1.790
Hong Kong 1.675
Jacksonville 1.387
Wilmington 1.152
Seattle 1.142
Cambridge 1.050
Ann Arbor 969
Dearborn 969
London 835
Nyköping 828
Beijing 664
Seoul 637
Chicago 614
Modena 526
Los Angeles 511
Helsinki 494
San Diego 367
Dallas 319
Princeton 301
Sofia 278
New York 270
The Dalles 266
Ho Chi Minh City 253
Eugene 235
Izmir 202
Buffalo 197
Moscow 189
Milan 188
Shanghai 179
São Paulo 170
Munich 168
Council Bluffs 162
Hanoi 160
Rome 156
Des Moines 154
Redwood City 145
Jakarta 143
Bologna 137
Salt Lake City 132
San Jose 103
Columbus 92
Bremen 88
Falls Church 77
Phoenix 75
Tokyo 72
Parma 69
Warsaw 68
Elk Grove Village 67
Brussels 66
Toronto 63
Philadelphia 60
Yalova 60
Montreal 59
Ottawa 59
Tampa 59
Dublin 58
Kent 58
Brooklyn 57
Boardman 55
Frankfurt am Main 53
Nuremberg 49
Rio de Janeiro 49
Stockholm 49
Guangzhou 47
Norwalk 47
Amsterdam 46
San Francisco 46
Florence 45
Nanjing 45
Turku 45
Fremont 44
Denver 43
Redondo Beach 42
San Mateo 41
Belo Horizonte 39
Kilburn 38
Johannesburg 37
Verona 37
Atlanta 36
Brasília 36
Rimini 36
Reggio Emilia 35
Boston 34
Chennai 33
Kunming 32
Bari 30
Miami 30
Paris 30
Orem 29
Sterling 29
Turin 28
Dhaka 27
Totale 43.022
Salva come PNG Salva come JPEG
Nome #
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 650
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 402
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 386
Hereditary hemochromatosis--a new look at an old disease. 383
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 366
Coproporphyrin excretion in healthy newborn babies 364
Association between celiac disease and idiopathic dilated cardiomyopathy: a case report. 362
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 357
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 356
Non-HFE Hepatic Iron Overload. 349
Ferroportin disease: Pathogenesis, diagnosis and treatment 343
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 342
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 339
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 335
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 333
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 326
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene 325
Primary hypoparathyroidism is common in adult patients with b-thalassemia and protect patients from osteoporosis. 316
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 313
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 310
Human macrophage ferroportin biology and the basis for the ferroportin disease 310
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 306
An unfortunate case of post-ERCP complications 302
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription 301
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 301
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 301
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 299
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 293
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 293
ER stress controls iron metabolism through induction of hepcidin. 289
Haptoglobin modifies the hemochromatosis phenotype in mice 288
VITAMIN-E SUPPLEMENTATION PREVENTS HEPATIC CIRRHOSIS DUE TO IRON OVERLOAD IN RODENTS 287
Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: Evidence for a role in hepcidin induction by inflammation in male mice 287
Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents 286
The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression 285
Duodenal ferritin synthesis in genetic hemochromatosis 285
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 285
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 285
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 284
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis. 284
Heterogeneity of hemochromatosis in Italy 283
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 283
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 279
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 279
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 278
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 278
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 277
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 276
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 275
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy 273
MOLECULAR AND CELLULAR ASPECTS OF IRON-INDUCED HEPATIC CIRRHOSIS IN RODENTS 271
3-hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo 271
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 271
Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. 270
Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion 270
Liver gene expression during chronic dietary iron overload in rats 267
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 266
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB 266
Lipid composition and fluidity of liver plasma membranes from rats with chronic dietary iron overload. 265
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 265
Comorbidity does not mean clinical complexity: evidence from the RePoSI register 265
The impact of inherited thrombophilia on liver transplantation. 263
The SMAD pathway is required for hepcidin response during endoplasmic reticulum stress 260
Missed treatment in an Italian HBV infected patients cohort: HBV RER 257
Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. 256
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload 254
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 252
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis 250
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 248
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 246
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment 244
Diacerhein blocks iron regulatory protein activation in inflamed human monocytes 243
DNA repair in lymphocytes from humans and rats with chronic iron overload. 243
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 243
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 242
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 242
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 242
Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum 241
Reducing the risk of hospital admission: A call to action from the Italian Society of Internal Medicine 241
Haemochromatosis 241
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 241
Antioxidant activity of silybin in vivo during long-term iron overload in rats 240
Disease progression and liver cancer in the ferroportin disease 239
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene 239
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 239
The penetrance of hemochromatosis: mice to the rescue. 238
Thyroid volume in adult beta-thalassemic patients is smaller than in controls 237
Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? 237
Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years since Hepcidin 237
Huh-7: a human hemochromatotic cell line. 234
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 234
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 232
Lack of enterocyte iron accumulation in the ferroportin disease 231
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 229
Iron and steatohepatitis. 228
EASL International Concensus Conference on Hepatitis B - 13-14 September, 2002 Geneva, Switzerland Consensus Statement (Long version) 228
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 228
Luspatercept Increases Hemoglobin, Decreases Transfusion Burden and Improves Iron Overload in Adults with Beta-Thalassemia 227
Gene expression of urea cycle enzymes following two-thirds partial hepatectomy in the rat. 225
GLUCONEOGENIC SIGNALS DIRECTLY CONTROL IRON HOMEOSTASIS THROUGH HEPCIDIN 224
Totale 28.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 244.307
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 244.307
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.087 0 0 0 0 0 614 775 825 271 685 496 421
2021/20225.494 284 581 517 380 223 271 393 295 619 436 861 634
2022/20235.388 612 563 348 504 647 824 114 592 645 86 244 209
2023/20243.601 169 221 511 298 529 273 301 425 133 188 192 361
2024/202512.875 675 150 341 856 2.182 1.813 773 698 1.227 768 1.768 1.624
2025/202612.317 1.709 1.253 2.283 2.289 2.710 2.073 0 0 0 0 0 0
Totale 61.033